Policy Analysis Inc. (PAI) and BresMed, two leading health-economics and outcomes research consultancies, are pleased to announce that they are joining forces to assist biopharma companies and other life sciences organizations in expanding their use of the new cloud-based modeling platform, heRo3. […]
Evidence-based vs Consensus-based Guidelines in Clinical Practice
There exists a "fundamental misunderstanding" about the distinction between evidence-based and consensus-based guidelines in clinical practice, the authors of a recent article published on JAMA write. "In this Viewpoint, we suggest that this distinction represents a fundamental misunderstanding of […]
eyeforpharma Webinar to Talk Impact of RWE on RCTs
Real-world evidence (RWE) and how it could impact randomized clinical trials (RCTs) will take center stage during an upcoming webinar being offered by eyeforpharma. The webinar is set to begin 9:30 a.m. EST Tuesday, July 23. Panelists include: Sebastian Schneeweiss, professor of medicine and […]
ICER President Makes Case for QALY
Steven Pearson, president of the Institute for Clinical and Economic Review (ICER), in a recent commentary dives into why the quality-adjusted life year, or QALY, is a metric worth keeping. Pearson writes that clinical studies frequently measure health gains through "disease-specific measures" like […]
NPR Report Spotlights ICER
A recent report by NPR highlights the increasing influence of an organization which has been branded the "biggest threat" to big pharma: The Institute for Clinical and Economic Review (ICER). The nonprofit drug pricing watchdog has made a name for itself as it produces reports on whether a drug is […]
Infographic Spotlights Impact of Testing
Each test ordered as part of a patient's care can have an impact on how care services are delivered, according to Quest Diagnostics. Quest Diagnostics in an infographic outlines how lab tests can bolster care and support the Triple Aim. "You'll see how each test adds value to care delivery, […]
Article Proposes Key Concepts for Journal Indicators
The authors of a recent article published in Nature outline how the future of journal indicators should be designed and implemented. According to a report by The Publication Plan, the authors of the article suggest the "next generation" of indicators should, among other things, possess a set role […]
PhRMA: International Reference Pricing Carries Negative Consequences for Patients
International reference pricing and other government-mandated pricing measures carry negative consequences for the patient, a recent post by PhRMA suggests. Access to new medicines, the post states, is significantly hampered by international pricing indices. "Nearly 90% of new medicines launched […]
Report Takes Deep Dive into Machine Learning
A recent report published in Value in Health offers a high-level look at the role of machine learning for health care outcomes researchers and decision makers. The report, "Machine Learning for Health Services Researchers," spotlights a number of key topics, including estimators, an algorithm which […]
Meeting Spotlights RCTs, RWE in Regulatory Setting
View a 6-hour video of Day 1 of Duke Margolis meeting entitled "Leveraging Randomized Clinical Trials to Generate RWE for Regulatory Purposes," highlighting actual trials and case examples that have been or are in the process of being implemented for regulatory labeling. Presentations include RWE […]
Incerti: Use Value Assessments to Bolster Population’s Health
The American Journal of Managed Care recently caught up with Devin Incerti, the Innovation and Value Initiative's lead economist, who discussed value assessments and their role in a population's well-being. "I think maybe one of the first questions that I always ask myself is, 'What is really the […]
Deloitte’s Reh Talks Manufacturing Innovation
Deloitte's Greg Reh in a recent post highlighted a panel discussion during the Financial Times US Pharma and Biotech Summit that focused on innovations in manufacturing, and what steps were necessary to prepare. "While science is advancing exponentially, questions remain whether our health care […]
Article Spotlights All-Payer Claims Databases
A recent article published in Health Affairs looks at how all-payer claims databases (APCDs) can be used to analyze how Americans navigate the U.S. health care system. Few studies aimed at analyzing how individuals move through the system have utilized APCDs partially due to their complex nature, […]
Franklin: Ban QALY in U.S.
Elizabeth Franklin, executive director of the Cancer Policy Institute at the Cancer Support Community headquarters in Washington, says the U.S. should ban "discriminatory measures" like the quality-adjusted life year (QALY) metric. "Organizations determining value must be completely transparent and […]
More on ICER’s Report on DMD Treatments
A recent report by Endpoint News takes a look at the Institute for Clinical and Economic Review's (ICER) recent report on treatments for Duchenne muscular dystrophy. ICER reviewed Sarepta Therapeutics' eteplirsen and golodirsen, as well as PTC Therapeutics' deflazacort. The drug pricing watchdog in […]
Germany Agency Calls for Drug Development, Approval Reforms
The Institute for Quality and Efficiency in Health Care (IQWiG) is calling for international reforms to the drug development and approval cycles, FiercePharma reports. According to the report, the agency found that only 25 percent (54) of 216 approvals between 2011 and 2017 delivered major health […]
FDA’s Woodcock Talks Big Changes
Janet Woodcock, chief of the FDA's Center for Drug Evaluation and Research, recently discussed a host of key changes being made at the agency, according to an Endpoint News report. According to the report, Woodcock touched on changes to clinical trial designs and other aspects of drug […]
Frenova Goes Global
Frenova Renal Research is looking outward as it aims to expand its scope beyond North America, the organization announced Thursday, July 11. According to a press release, the expansion will enable the organization to "broaden its reach and provide researchers centralized access to an exponentially […]
What Does Machine Learning Hold for Clinical Trials?
A recent article by Precision for Value's Kellie Rademacher published on Clinical Leader spotlights how machine learning can impact clinical trials. The opportunities that arise from bringing machine learning into the drug development pipeline "seem limitless," Rademacher writes. "While the […]
Report Offers Insight into Value-Based Model
A new report from Prognos, "Success in Managed Markets: Payer Insights," takes a deep dive into the value-based model and its future. The report offers insights into some of the challenges for payers in the value-based paradigm, including "demonstrating outcomes, evidence of cost reduction and […]
Article Spotlights Growing Use of RWE
A recent article published in ISPOR's Value in Health spotlights the growing focus on real-world evidence (RWE) and real-world data (RWD). "In a recent PubMed search, the number of publications that included these terms in the title and abstract has increased by more than 17 times — from 177 […]
More on ACA Hearing
A federal court heard arguments on the constitutionality of the Affordable Care Act health care mandate this week. To read about the 90-minute hearing, click here to read Fierce Healthcare's report. […]
ISPOR Plans Webinar on Machine Learning
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a July 30 webinar on using machine learning for prediction in HEOR. The online event is set to begin noon EST July 30. "[The webinar] will begin by framing the prediction problem and drawing both […]
ISPOR Launches Presentations Database
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) this week launched the ISPOR Presentations Database, a new HEOR resource. "The ISPOR Presentations Database is one of the most utilized HEOR resources that the society offers," the society said in a press […]
Tool Helps Consumers Find Cheaper Treatment Options
Some health systems in the U.S. have adopted a new pricing tool aimed at helping patients find cheaper treatment options, Kaiser Health News reports. Minnesota-based Allina Health is among the few health systems using the pricing tool, according to the report, which gives physicians access to […]
Report: Some Patients Head to Canada for Cheaper Insulin
Left with few alternatives as insulin prices continue trending up, some U.S. diabetics have opted to buy insulin in Canada, where the drug can be 90 percent cheaper, according to a Kaiser Health News and PBS NewsHour report. The report follows a Canada-bound caravan of individuals seeking cheaper […]
Uncertainty Abound on ACA Mandate
The fate of the Affordable Care Act's health care mandate remains uncertain after a hearing Tuesday in which a panel of federal appeals court judges listened to oral arguments on the rule's constitutionality, the New York Times reports. It remains unclear, according to the report, what scrapping […]
Opinion: Cut Prices to Boost Medication Adherence
Bringing down the cost of medicines in the U.S. to a more widely-affordable range could boost adherence to medication, Peter Pitts, former Food and Drug Administration associate commissioner, writes in a column published on the Washington Times. Pitts writes that some 125,000 Americans are likely […]
Judge Blocks Trump’s Rule on Drug Prices in DTC Ads
A federal judge this week blocked the Trump administration's rule requiring pharmaceutical companies include a drug's list price in television ads, STAT reports. The decision argues Health and Human Services (HHS) had insufficient authority to force drugmakers to disclose list prices in TV ads, and […]
Hearing Today on ACA’s Constitutionality
A hearing today, July 9, at the 5th Circuit Court of Appeals in New Orleans could decide whether a federal judge's ruling that the Affordable Care Act is unconstitutional will stick. According to a Kaiser Health News report, the hearing is poised for the Supreme Court, and could play a key role in […]
